As of 4:33:47 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-192,986.0000
-286,663.0000
-358,915.0000
-346,445.0000
-156,387.0000
Investing Cash Flow
80,238.0000
182,095.0000
67,880.0000
-102,429.0000
-109,002.0000
Financing Cash Flow
54,681.0000
54,681.0000
223,934.0000
--
918,514.0000
End Cash Position
61,937.0000
139,747.0000
189,573.0000
247,322.0000
693,354.0000
Capital Expenditure
--
--
-7,089.0000
-383.0000
-9,001.0000
Issuance of Capital Stock
59,281.0000
59,281.0000
250,482.0000
--
974,728.0000
Free Cash Flow
-192,986.0000
-286,663.0000
-366,004.0000
-346,828.0000
-165,388.0000
12/31/2020 - 3/17/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VICO.ST Vicore Pharma Holding AB (publ)
9.12
+7.93%
ATORX.ST Alligator Bioscience AB (publ)
0.2525
+1.41%
XBRANE.ST Xbrane Biopharma AB (publ)
0.1750
+8.83%
SANION.ST Saniona AB (publ)
7.85
-2.36%
HNSA.ST Hansa Biopharma AB (publ)
39.98
+1.99%
DBP-B.ST Double Bond Pharmaceutical Int.
0.3870
+2.65%
BIOVIC-B.ST Biovica International AB (publ)
1.9960
-0.20%
SIMRIS-B.ST Simris Group AB (PUBL)
0.1005
+31.89%
ONCO.ST Oncopeptides AB (publ)
1.5840
+1.80%
CYXO.ST Cyxone AB (publ)
0.0180
0.00%